Effect of 5-Alpha Reductase Inhibitors on Magnetic Resonance Imaging and Prostate Cancer Detection [PDF]
BiomoleculesConcerns exist regarding the effects of 5-alpha reductase inhibitors (5-ARIs) on multipa-rametric magnetic resonance imaging (mpMRI) and clinically significant prostate cancer (csPCa) detection.
Juan Morote +10 more
doaj +2 more sources
Management of patients with lower urinary tract symptoms due to benign prostatic enlargement at risk of progression treated with 5-alpha-reductase inhibitors: examining real-world clinical practice in Spain and Brazil [PDF]
BMC UrologyBackground For patients with lower urinary tract symptoms due to benign prostatic enlargement (LUTS/BPE), assessing patient risk of disease progression is important to determine if treatment with 5-alpha-reductase inhibitors (5ARIs) is warranted ...
Juan Manuel Palacios +7 more
doaj +2 more sources
The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia [PDF]
Asian Journal of Urology, 2018 Benign prostatic hyperplasia (BPH) is characterized by an enlarged prostate, lower urinary tract symptoms (LUTS), and a decreased urinary flow rate. Common in older men, BPH is a progressive disease that can eventually lead to complications including ...
Eric H. Kim +2 more
doaj +2 more sources
Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis
The World Journal of Men's Health, 2020 Purpose: Although five-alpha reductase inhibitor (5-ARI) is one of standard treatment for benign prostatic hyperplasia (BPH) or alopecia, potential complications after 5-ARI have been issues recently.
Jae Heon Kim +5 more
doaj +4 more sources
The Long-Term Impact of 5-alpha Reductase Inhibitors on the Development of Bladder Cancer and the Need for Radical Cystectomy: A Nationwide Observational Study [PDF]
The World Journal of Men's HealthPurpose: To investigate the long-term effects of taking 5-alpha reductase inhibitors (5ARIs) on the development of bladder cancer (BC) and the implementation of radical cystectomy (RC), a standard procedure for advanced BC.
Jong Hyun Pyun +5 more
doaj +2 more sources
5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis [PDF]
International Brazilian Journal of Urology, 2018 Objective: To assess the relationship between 5α-reductase inhibitors (5ARIs) and the risk of male breast cancer (MBC). Material and Methods: We systematically searched Medline via PubMed, Embase and the Cochrane Library Central Register up to May 2017 ...
Jiamin Wang +5 more
doaj +2 more sources
Battling prostate cancer with 5-alpha-reductase inhibitors: a pyrrhic victory? [PDF]
J Gen Intern Med, 2011 Given the relatively small impact of prostate cancer screening on cancer mortality, experts are now suggesting that chemoprevention with 5-alpha-reductase inhibitors (5-ARI) may be a more effective strategy for cancer control. Two large placebo-controlled randomized trials found that men receiving 5-ARI were about 25% less likely than controls to be ...
Hoffman RM, Roberts RG, Barry MJ.
europepmc +4 more sources
Post-finasteride syndrome, [PDF]
Anais Brasileiros de Dermatologia, 2020 Finasteride is a 5α-reductase enzyme inhibitor that has been approved for the treatment of male androgenic alopecia since 1997. Over time, it has been considered a safe and well-tolerated drug with rare and reversible side effects.
Ana Francisca Junqueira Ribeiro Pereira +1 more
doaj +1 more source
5-alpha-reductase inhibitors and risk of cardiovascular diseases
Urological Science, 2015 Teng-Fu Hsieh +5 more
doaj +2 more sources
5-alpha-reductase inhibitors and risk of diabetes mellitus
Urological Science, 2016 Teng-Fu Hsieh +5 more
doaj +2 more sources